Roivant Sciences(ROIV) - 2026 Q1 - Quarterly Results

Exhibit 99.1 Roivant Reports Financial Results for the First Quarter Ended June 30, 2025, and Provides Business Update BASEL, Switzerland and LONDON and NEW YORK, August 11, 2025 – Roivant (Nasdaq: ROIV) today reported its financial results for the first quarter ended June 30, 2025, and provided a business update. "I am proud of our continued execution in this quarter, including clinical progress across our programs and the completion of our initial $1.5 billion share repurchase program," said Matt Gline, C ...